POLYETHYLENE GLYCOL 3350 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polyethylene Glycol 3350, and when can generic versions of Polyethylene Glycol 3350 launch?
Polyethylene Glycol 3350 is a drug marketed by Ani Pharms, Annora Pharma, Aurobindo Pharma Ltd, Breckenridge Pharm, Elysium, Lgm Pharma, Mylan, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharms Inc, Paddock Llc, Ppi-dac, Strides Pharma, and Teva Pharms. and is included in eighteen NDAs.
The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLYETHYLENE GLYCOL 3350?
- What are the global sales for POLYETHYLENE GLYCOL 3350?
- What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350?
Summary for POLYETHYLENE GLYCOL 3350
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 18 |
| Finished Product Suppliers / Packagers: | 63 |
| Raw Ingredient (Bulk) Api Vendors: | 218 |
| Clinical Trials: | 305 |
| DailyMed Link: | POLYETHYLENE GLYCOL 3350 at DailyMed |
Recent Clinical Trials for POLYETHYLENE GLYCOL 3350
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospitals Cleveland Medical Center | Phase 4 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Jinling Hospital, China | N/A |
Pharmacology for POLYETHYLENE GLYCOL 3350
| Drug Class | Osmotic Laxative |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202850-001 | Dec 15, 2015 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 203928-002 | Aug 24, 2016 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 078915-001 | Oct 6, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
